KUKJE PHARMA Co., Ltd. (002720.KS) KSC

Currency In KRW

AD

Valuation

Market Cap87.65B
Enterprise Value107.35B
P/E Ratio13.4
PEG Ratio-0.57
Price/Sales Ratio0.38
Price/Book Ratio0.68
Enterprise/Revenue0.47
Enterprise/EBITDA9.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue175.5B
Revenue/Share8,566.55
Gross Profit92.97B
EBITDA9.41B
Net Income5.7B
Diluted EPS279.51

Balance Sheet

Total Cash15.72B
Total Cash/Share743.02
Total Debt31.39B
Total Debt/Equity0.32
Current Ratio1.14
Book Value Per Share4,696.15

Price History

52-Week Change-31.67
52-Week High5,470
52-Week Low2,810
Moving Average 50 Days3,348.5
Moving Average 200 Days4,194.18

Statistics

Average Volume62,320
Shares Outstanding21.16M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate30
Trailing Annual Dividend Yield0.93
Payout Ratio0.13
Last Split Factor21:20
Last Split DateMarch 17, 2023
AD